Global Aortic Endografts Market Size By Types (Abdominal Aortic Endografts, Thoracic Aortic Endografts), By Application (Hospitals, Clinics), By Site (Infrarenal, Pararenal), By Geographic Scope And Forecast

Aortic Endografts Market Size And Forecast

Aortic Endografts Market size was valued at USD 2.3 Billion in 2024 and is projected to reach USD 5.9 Billion by 2031, growing at a CAGR of 6.5% from 2024 to 2031

Continuous advancements in endovascular surgical procedures and technology are projected to increase the growth of the market over the next few years. The Global Aortic Endografts Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Aortic Endografts Market Drivers

The market drivers for the Aortic Endografts Market can be influenced by various factors. These may include

• Growing Prevalence of Aortic Aneurysms One major factor propelling the market for aortic endografts is the rising incidence of aortic aneurysms, both thoracic and abdominal. Worldwide, the prevalence of aortic aneurysms is on the rise due to a number of factors including aging populations, hypertension, smoking, and genetic predispositions.
• Technological Developments in Endovascular Surgery Techniques The safety and effectiveness of aortic endografts have been enhanced by developments in endovascular surgery techniques, including imaging modalities, device designs, and less invasive procedures. Because of these developments, a greater number of patients are now eligible for endovascular repair rather than open surgery.
• Preference for Minimally Invasive operations Due to their shorter hospital stays, quicker recovery periods, and lower rates of morbidity and mortality when compared to open surgical approaches, patients and doctors are beginning to favor minimally invasive operations more and more. The acceptance of aortic endografts is fueled by the minimally invasive alternative to open surgery that they provide for the treatment of aortic aneurysms.
• Aging Population and Increasing Healthcare Costs Aortic endograft treatments are becoming more and more popular as the world’s population ages and becomes more vulnerable to aortic illnesses. Furthermore, rising healthcare costs, particularly in industrialized nations, make advanced endovascular treatments for aortic diseases more accessible.
• knowledge and Screening Programs Early diagnosis and treatment of aortic illnesses are facilitated by growing knowledge of the hazards associated with aortic aneurysms and the significance of early detection through screening programs. Aortic endografts are therefore being used to treat and diagnose a greater number of patients, which is driving market expansion.
• Regulatory Approvals and Reimbursement rules Incentives to choose aortic endograft operations include favorable regulatory approvals and reimbursement rules in many different countries, which incentivize medical professionals and patients to pursue these therapies. Expanding markets are facilitated by streamlined regulatory processes and sufficient compensation.
• Technological Advancements and Product Development The performance, robustness, and practicality of aortic endografts are improved via ongoing innovation in their designs, materials, and delivery methods. Physicians and patients are drawn to new product launches and developments in endograft technology, which propels market expansion.
• Growth of Emerging Markets The market for aortic endografts is expected to continue to grow as a result of rising healthcare infrastructure development and easier access to cutting-edge medical technology in these regions. Demand is driven in these regions by greater knowledge of aortic illnesses, better healthcare systems, and rising disposable incomes.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Aortic Endografts Market Restraints

Several factors can act as restraints or challenges for the Aortic Endografts Market. These may include

• High Procedure Costs Aortic endograft endovascular repair operations can be costly, which makes treatment more difficult for patients in areas with insufficient insurance or pay-out-of-pocket policies. Procedures can be too expensive, which could discourage patients from obtaining therapy or lead medical professionals to choose less expensive alternatives.
• Procedure Complexity and Training Needs Endovascular aortic aneurysm repair calls for specific knowledge and training for medical practitioners. The use of aortic endografts may be restricted due to the intricacy of the operations and the requirement for continual education and proficiency in interventional techniques, particularly in areas with restricted access to qualified healthcare workers and specialized equipment.
• Risk of Adverse Events and Complications Despite being minimally invasive, endovascular treatments involving aortic endografts still have a chance of complications such graft migration, endoleaks, and adverse events connected to the device. Patients’ and doctors’ preferences may be influenced by worries about possible side effects and the requirement for ongoing monitoring, which could result in a cautious approach to care.
• Limited Suitable for Complex Anatomy Patients with complex aortic anatomy, such as those with significant tortuosity, calcification, or thrombosis, may not be a good candidate for aortic endografts. Alternative treatment options may be required in specific patient populations because to the constraints in device design and deployment techniques that may limit the applicability of endovascular repair.
• Extended Sturdiness and Maintenance Needs There is still uncertainty about the long-term viability of aortic endografts, especially in younger patients who have higher life expectancies. Endovascular repair is more expensive and complex overall due to the requirement for ongoing surveillance and monitoring to identify and treat possible complications. This has an effect on patient outcomes and the use of healthcare resources.
• Regulatory and Reimbursement Obstacles Strict regulations and reimbursement guidelines may make it difficult for innovative aortic endograft technologies to enter the market and be adopted. Market expansion and innovation in the industry may be hampered by delays in regulatory approvals, coverage restrictions, and reimbursement hurdles.
• Aortic endograft endovascular repair is facing competition from emerging alternative therapies, including hybrid procedures, open surgical repair, and transcatheter approaches. These therapies are constantly evolving and posing a threat to endovascular repair. Alternative therapy developments could provide results that are on par with or better than aortic endografts, putting aortic endografts in jeopardy.
• Litigation risks and public perception Unfavorable press concerning the effectiveness and safety of aortic endografts, together with possible legal ramifications from device-related issues, can cause patients’ and doctors’ trust in these therapies to decline. Market expansion and adoption rates may be impacted by public opinion and media attention, particularly in situations involving unfavorable incidents or product recalls.

Global Aortic Endografts Market Segmentation Analysis

The Global Aortic Endografts Market is segmented on the basis of Types, Application, Site, and Geography.

Aortic Endografts Market, By Types

• Abdominal Aortic Endografts• Thoracic Aortic Endografts• Fenestrated and Branched Aortic Endografts• Flow Diverting Aortic Endografts

Based on Types, the market is bifurcated into Abdominal Aortic Endografts, thoracic Aortic Endografts, fenestrated and Branched Aortic Endografts, and flow Diverting Aortic Endografts. The Abdominal Aortic Endografts segment and Thoracic Aortic endografts segments are seeing a spike in the current scenario. At least in the short term, this device showed to be beneficial in protecting the patient treated against aneurysm rupture. The presence of even significant tortuosity of the proximal neck and of the iliac arteries had no effect on the result of the study.

Aortic Endografts Market, By Application

• Hospitals• Clinics

Based on Application, the market is segmented into Hospitals and Clinics. Hospital setups are the most commonly used segments that use aortic endografts when compared with the clinical setup. Hence hospitals have a huge potential for sales and aortic endograft companies can target it. Catheters, which are thin, long tubes that are used to insert stents enclosed by a fabric liner to reinforce weak regions in the aorta, are used in endovascular surgery.

Aortic Endografts Market, By Site

• Infrarenal• Pararenal

Based on Site, the market is segmented into Infrarenal and Pararenal. The pararenal segments are further segmented into juxta renal and super renal. Aortic endograft fixed suprarenal appears to be a safe choice for individuals who have a short or conical proximal aortic neck, according to preliminary findings. However, there is still some concern about the long-term effect on the renal function when the uncovered stent crosses the renal artery ostia (or blood vessels).

Aortic Endografts Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

Based on Geography, the Global Aortic Endografts Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Because of factors such as the high concentration of healthcare firms in the United States and developed healthcare infrastructure, North America is one of the main consumers of the Global Aortic Endografts Market.

Key Players

The “Global Aortic Endografts Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Medtronic Plc, Becton, Dickinson and company, Cardinal Health Inc, Endologix Inc, Lombard Medical Inc, Koninklijke Philips N.V., Terumo Medical Corporation, W.L. Gore & Associates Inc and Cook medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We'll dive deep into the market using both number-crunching (quantitative) and understanding the "why" (qualitative) by breaking it down into manageable segments considering all sorts of factors, not just money. You'll get the market size (in USD Billion) for each of these segments and smaller sub-segments. We'll pinpoint which areas and groups are expected to grow the fastest and which ones will likely be the biggest. We'll also look at how the product/service is actually used in different regions, and what's influencing the market there. See who the big players are and how they stack up against each other, including details on their recent product launches, partnerships, expansions, and acquisitions over the last five years. We'll give you detailed company profiles too, covering everything from an overview and key insights to product comparisons and a SWOT analysis. You'll also get our take on the current and future state of the industry, including emerging opportunities, growth drivers, and potential roadblocks in both up-and-coming and mature markets. We'll use Porter's Five Forces to analyze the market from every angle and map out the market's Value Chain, showing you how everything connects. Finally, we'll discuss market trends and opportunities for growth in the future, and provide 6 months of analyst support after the sale.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.